易生活(00223.HK):法證調查及內部監控審查已完成 續停牌
易生活控股(00223.HK)公布,有關公司延遲發出2024年中期業績及報告的法證調查及內部監控審查已完成,公司委聘的獨立調查員凱晉企業顧問已完成法證調查,調查範圍包括前董事會成員涉及中國附屬公司不尋常交易的指控,以及相關收入、成本及投資活動文件缺失等問題,報告已提交聯交所審閱。
同時,公司委託的信永方略風險管理已完成內部監控審查及跟進審查,涵蓋2024年4月至2025年3月期間集團內部監控系統及程序,報告亦已提交聯交所。
應易生活要求,其股份已自2024年12月2日起暫停買賣,並將繼續停牌直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.